X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-12-22 | ABTC | American Bitcoin Corp. | Busch Richard | Dir | P - Purchase | $1.98 | +101,000 | 1,000,975 | +11% | +$199,980 | ||||||
2026-01-13 | ACRV | Acrivon Therapeutics, Inc. | Devroe Eric | COO | P - Purchase | $1.72 | +10,000 | 75,308 | +15% | +$17,218 | ||||||
2026-01-14 | ACRV | Acrivon Therapeutics, Inc. | Levy Adam D. | CFO | P - Purchase | $1.70 | +8,832 | 20,983 | +73% | +$14,999 | ||||||
2026-01-14 | ACRV | Acrivon Therapeutics, Inc. | Blume-Jensen Peter | Pres, CEO | P - Purchase | $1.68 | +49,000 | 2,410,477 | +2% | +$82,124 | ||||||
2025-12-31 | ADMQ | Adm Endeavors, Inc. | Johnson Marc | CEO | P - Purchase | $0.05 | +210,500 | 61,319,438 | 0% | +$10,104 | ||||||
| M | 2025-12-19 | AGIG | Abundia Global Impact Group, Inc. | Gillespie Edward Oliver | CEO | P - Purchase | $1.85 | +38,461 | 38,461 | New | +$71,261 | |||||
2025-12-19 | AGIG | Abundia Global Impact Group, Inc. | Henninger Matthew T. | Dir | P - Purchase | $1.74 | +9,500 | 9,500 | New | +$16,530 | ||||||
2025-12-23 | AGIG | Abundia Global Impact Group, Inc. | Gillespie Edward Oliver | CEO | P - Purchase | $1.92 | +12,500 | 50,961 | +33% | +$23,938 | ||||||
2026-01-15 | AIRJ | Airjoule Technologies Corp. | Porter Stuart D | Dir, 10% | P - Purchase | $3.25 | +153,846 | 19,532,653 | +1% | +$500,000 | ||||||
2026-01-15 | AIRJ | Airjoule Technologies Corp. | Eilers Patrick C | Exec COB | P - Purchase | $3.25 | +76,923 | 4,593,750 | +2% | +$250,000 | ||||||
2026-01-15 | AIRJ | Airjoule Technologies Corp. | Jore Matthew B | CEO, 10% | P - Purchase | $3.25 | +7,692 | 7,718,123 | 0% | +$24,999 | ||||||
| D | 2025-12-29 | AISP | Airship Ai Holdings, Inc. | Allen Paul M. | Pres | P - Purchase | $2.74 | +100,000 | 151,948 | +193% | +$274,270 | |||||
2026-01-15 | AKAN | Akanda Corp. | Hrt Financial LP | 10% | P - Purchase | $1.40 | +29,036 | 7,816 | -137% | +$40,650 | ||||||
2025-12-23 | ALT | Altimmune, Inc. | Gill John | Dir | P - Purchase | $4.10 | +12,500 | 12,500 | New | +$51,250 | ||||||
2026-01-08 | ALT | Altimmune, Inc. | Pisano Wayne | Dir | P - Purchase | $4.08 | +5,000 | 13,498 | +59% | +$20,410 | ||||||
2026-01-13 | ASST | Strive, Inc. | Cole Matthew Ryan | CEO | P - Purchase | $0.92 | +500,000 | 1,200,380 | +71% | +$459,350 | ||||||
2025-12-19 | BMNM | Bimini Capital Management, Inc. | Griffith Ashley B | Dir | P - Purchase | $1.55 | +50,000 | 50,000 | New | +$77,500 | ||||||
2025-12-19 | BMNM | Bimini Capital Management, Inc. | Haas G Hunter IV | CFO, 10% | P - Purchase | $1.55 | +192,247 | 1,491,517 | +15% | +$297,983 | ||||||
2025-12-19 | BMNM | Bimini Capital Management, Inc. | Cauley Robert E | CEO, 10% | P - Purchase | $1.55 | +192,248 | 1,560,215 | +14% | +$297,984 | ||||||
2025-12-19 | BMNM | Bimini Capital Management, Inc. | Dwyer Robert J | Dir, 10% | P - Purchase | $1.55 | +100,000 | 1,476,339 | +7% | +$155,000 | ||||||
| M | 2025-12-26 | BUKS | Butler National Corp | Daly Joseph Patrick | Dir, 10% | P - Purchase | $2.98 | +7,322 | 8,852,322 | 0% | +$21,850 | |||||
2026-01-12 | BUKS | Butler National Corp | Loh Michael Anthony | Dir | P - Purchase | $2.87 | +8,000 | 134,342 | +6% | +$22,956 | ||||||
2025-12-26 | CHUC | Charlie'S Holdings, Inc. | Carmines Edward | Dir | P - Purchase | $0.28 | +100,000 | 2,006,481 | +5% | +$27,600 | ||||||
| M | 2025-12-29 | CLPR | Clipper Realty Inc. | Levinson Sam | Dir, 10% | P - Purchase | $3.71 | +58,263 | 8,923,360 | +1% | +$216,031 | |||||
2026-01-05 | CLYM | Climb Bio, Inc. | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $3.50 | +7,111 | 11,300,939 | 0% | +$24,889 | ||||||
| M | 2025-12-24 | COCP | Cocrystal Pharma, Inc. | Frost Phillip Md Et Al | Dir, 10% | P - Purchase | $0.97 | +65,000 | 1,795,651 | +4% | +$63,202 | |||||
2025-12-30 | COCP | Cocrystal Pharma, Inc. | Frost Phillip Md Et Al | Dir, 10% | P - Purchase | $0.97 | +20,000 | 1,815,651 | +1% | +$19,310 | ||||||
2025-12-31 | COCP | Cocrystal Pharma, Inc. | Frost Phillip Md Et Al | Dir, 10% | P - Purchase | $0.95 | +50,000 | 1,865,651 | +3% | +$47,275 | ||||||
2026-01-06 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.54 | +133,953 | 6,850,724 | +2% | +$72,000 | ||||||
2026-01-07 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.52 | +124,880 | 6,975,604 | +2% | +$65,000 | ||||||
2026-01-08 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.52 | +156,190 | 7,131,794 | +2% | +$81,000 | ||||||
2026-01-12 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.50 | +113,185 | 7,244,979 | +2% | +$57,000 | ||||||
2026-01-14 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.45 | +493,495 | 7,738,474 | +7% | +$220,000 | ||||||
2026-01-20 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.50 | +353,321 | 8,091,795 | +5% | +$175,000 | ||||||
2025-12-30 | CUE | Cue Biopharma, Inc. | Sarraf Pasha | Dir | P - Purchase | $0.31 | +323,857 | 323,857 | New | +$99,747 | ||||||
| M | 2025-12-23 | DLTH | Duluth Holdings Inc. | Schlecht Richard W | SVP, Product Dev., Sourcing | P - Purchase | $2.19 | +28,554 | 440,893 | +7% | +$62,394 | |||||
2025-11-26 | EFOI | Energy Focus, Inc/De | Huang Chiao Chieh | CEO, 10% | P - Purchase | $2.29 | +262,009 | 1,998,599 | +15% | +$600,001 | ||||||
2025-12-29 | ENTX | Entera Bio Ltd. | Toledano Miranda Jayne | CEO | P - Purchase | $1.81 | +11,000 | 426,575 | +3% | +$19,912 | ||||||
| M | 2025-12-29 | EP | Empire Petroleum Corp | Mulacek Phil E | Dir, 10% | P - Purchase | $3.00 | +5,451 | 8,038,529 | 0% | +$16,353 | |||||
| M | 2025-12-31 | EP | Empire Petroleum Corp | Mulacek Phil E | Dir, 10% | P - Purchase | $2.99 | +6,800 | 8,045,329 | 0% | +$20,363 | |||||
2025-12-22 | FNGR | Fingermotion, Inc. | Leong Yew Poh | Dir | P - Purchase | $1.52 | +10,000 | 322,500 | +3% | +$15,150 | ||||||
2025-12-23 | GALT | Galectin Therapeutics Inc | Freeman Kevin D | Dir | P - Purchase | $3.55 | +5,500 | 137,269 | +4% | +$19,514 | ||||||
| A | 2025-12-23 | GALT | Galectin Therapeutics Inc | Freeman Kevin D | Dir | P - Purchase | $3.55 | +5,500 | 137,269 | +4% | +$19,514 | |||||
| A | 2025-12-23 | GALT | Galectin Therapeutics Inc | Freeman Kevin D | Dir | P - Purchase | $3.55 | +5,500 | 153,332 | +4% | +$19,514 | |||||
| D | 2025-12-18 | GBCS | Selectis Health, Inc. | Baller Lance | Dir, 10% | P - Purchase | $2.20 | +6,192 | 294,374 | +2% | +$13,622 | |||||
| M | 2025-12-19 | GPUS | Hyperscale Data, Inc. | Ault Milton C III | Exec COB, 10% | P - Purchase | $0.23 | +315,000 | 975,671 | +48% | +$73,323 | |||||
| M | 2025-12-23 | GPUS | Hyperscale Data, Inc. | Ault Milton C III | Exec COB, 10% | P - Purchase | $0.21 | +184,483 | 1,160,154 | +19% | +$38,611 | |||||
| M | 2025-12-30 | GPUS | Hyperscale Data, Inc. | Ault Milton C III | Exec COB, 10% | P - Purchase | $0.19 | +1,608,833 | 2,768,954 | +139% | +$298,862 | |||||
| M | 2026-01-05 | GTE | Gran Tierra Energy Inc. | Lm Asset (Im) Inc. | 10% | P - Purchase | $4.02 | +180,000 | 4,301,750 | +4% | +$724,346 | |||||
2026-01-07 | GTE | Gran Tierra Energy Inc. | Lm Asset (Im) Inc. | 10% | P - Purchase | $3.87 | +80,000 | 4,381,750 | +2% | +$309,712 | ||||||
| M | 2025-12-26 | HYPD | Hyperion Defi, Inc. | Strahlman Ellen R | Dir | P - Purchase | $3.66 | +30,880 | 126,030 | +32% | +$113,091 | |||||
2025-12-31 | HYPD | Hyperion Defi, Inc. | Knox David R. | CFO | P - Purchase | $3.59 | +27,950 | 327,950 | +9% | +$100,341 | ||||||
2026-01-12 | IMRX | Immuneering Corp | Feinberg Peter | Dir | P - Purchase | $4.35 | +20,000 | 1,161,064 | +2% | +$86,904 | ||||||
2026-01-13 | IMRX | Immuneering Corp | Neufeld Leah R | CHIEF PEOPLE OFFICER | P - Purchase | $4.15 | +2,626 | 25,970 | +11% | +$10,906 | ||||||
2026-01-15 | IMRX | Immuneering Corp | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | P - Purchase | $4.57 | +2,298 | 376,496 | +1% | +$10,502 | ||||||
2026-01-15 | IMRX | Immuneering Corp | Schall Thomas J. | Dir | P - Purchase | $4.67 | +21,645 | 74,530 | +41% | +$101,041 | ||||||
2026-01-16 | IMRX | Immuneering Corp | Brakewood Harold Eugene | Chief Business Officer | P - Purchase | $4.76 | +5,250 | 11,050 | +91% | +$24,990 | ||||||
2025-12-22 | IPSC | Century Therapeutics, Inc. | Cowan Chad | Chief Scientific Officer | P - Purchase | $0.85 | +58,060 | 1,055,784 | +6% | +$49,252 | ||||||
2025-12-29 | IRD | Opus Genetics, Inc. | Gallagher Cam | Dir | P - Purchase | $1.97 | +164,000 | 2,007,430 | +9% | +$323,693 | ||||||
2026-01-06 | IVFH | Innovative Food Holdings Inc | Pappas James C | Dir, 10% | P - Purchase | $0.30 | +505,555 | 10,414,722 | +5% | +$151,667 | ||||||
2026-01-06 | IVFH | Innovative Food Holdings Inc | Schmulen Mark | Dir | P - Purchase | $0.30 | +288,890 | 345,234 | +513% | +$86,667 | ||||||
2026-01-06 | IVFH | Innovative Food Holdings Inc | Smith Denver Johnson | Dir | P - Purchase | $0.30 | +505,555 | 4,844,130 | +12% | +$151,667 | ||||||
2026-01-06 | IVFH | Innovative Food Holdings Inc | Schubert Gary | CEO | P - Purchase | $0.30 | +166,666 | 532,569 | +46% | +$50,000 | ||||||
2025-12-30 | LFT | Lument Finance Trust, Inc. | Keenan Walter C | Dir | P - Purchase | $1.46 | +25,000 | 197,116 | +15% | +$36,448 | ||||||
2025-12-30 | LGL | Lgl Group Inc | Gabelli Mario J | 10% | P - Purchase | $4.75 | +95,387 | 1,072,999 | +10% | +$453,088 | ||||||
2025-12-31 | LSAK | Lesaka Technologies Inc | Mazanderani Ali | Exec COB | P - Purchase | $5.00 | +1,800,000 | 2,325,115 | +343% | +$9,000,000 | ||||||
| M | 2025-12-19 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | P - Purchase | $1.25 | +129,797 | 796,007 | +19% | +$162,834 | |||||
| M | 2025-12-29 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | P - Purchase | $1.03 | +148,502 | 647,505 | +30% | +$153,081 | |||||
| M | 2026-01-02 | LUCY | Innovative Eyewear Inc | Galkin Vladimir | 10% | P - Purchase | $1.79 | +647,505 | 0 | -100% | +$1,155,954 | |||||
| D | 2025-12-22 | MAIA | Maia Biotechnology, Inc. | Louie Ngar Yee | Dir | P - Purchase | $1.22 | +81,699 | 1,248,888 | +7% | +$100,000 | |||||
| D | 2025-12-22 | MAIA | Maia Biotechnology, Inc. | Chaouki Steven M | Dir | P - Purchase | $1.22 | +40,849 | 151,873 | +37% | +$49,999 | |||||
| D | 2025-12-22 | MAIA | Maia Biotechnology, Inc. | Smith Stan | Dir | P - Purchase | $1.22 | +57,189 | 1,435,218 | +4% | +$69,999 | |||||
| M | 2025-12-30 | MDBH | Mdb Capital Holdings, LLC | Marlett Christopher A | Co-Founder, 10% | P - Purchase | $3.26 | +8,787 | 166,720 | +6% | +$28,688 | |||||
| M | 2025-12-26 | MIGI | Mawson Infrastructure Group Inc. | Endeavor Blockchain, LLC | 10% | P - Purchase | $4.48 | +205,000 | 63,279 | -145% | +$917,550 | |||||
| M | 2026-01-09 | MIGI | Mawson Infrastructure Group Inc. | Endeavor Blockchain, LLC | 10% | P - Purchase | $4.56 | +182,018 | 85,297 | -188% | +$829,562 | |||||
| EM | 2025-12-26 | MRUS | Merus N.V. | Genmab A/S | 10% | P - Purchase | $1.33 | +76,922,983 | 0 | -100% | +$102,411,145 | |||||
2025-12-29 | NNUP | Nocopi Technologies Inc/Md/ | Westenburg Kevin Camerer | Pres | P - Purchase | $1.50 | +33,333 | 200,533 | +20% | +$50,000 | ||||||
2025-12-23 | NRXS | Neuraxis, Inc | Aharon Gil | Dir | P - Purchase | $3.52 | +286,138 | 286,138 | New | +$1,007,206 | ||||||
2025-12-26 | NWTG | Newton Golf Company, Inc. | Campbell Gregor Alasdair | Exec COB, CEO | P - Purchase | $1.59 | +10,000 | 335,945 | +3% | +$15,879 | ||||||
2026-01-16 | ONCY | Oncolytics Biotech Inc | Seizinger Bernd R. | Dir | P - Purchase | $1.04 | +100,000 | 466,991 | +27% | +$103,770 | ||||||
| M | 2025-12-30 | ONFO | Onfolio Holdings, Inc | Wells Dominic Benjamin James | CEO, CRO, Chair of Board, 10% | P - Purchase | $0.67 | +74,500 | 1,240,000 | +6% | +$49,713 | |||||
2025-12-19 | PLX | Protalix Biotherapeutics, Inc. | Bashan Dror | Pres, CEO | P - Purchase | $1.81 | +56,000 | 2,532,934 | +2% | +$101,360 | ||||||
| M | 2026-01-05 | PMCB | Pharmacyte Biotech, Inc. | Schechter Jonathan | Dir | P - Purchase | $0.80 | +60,000 | 192,500 | +45% | +$48,232 | |||||
| M | 2026-01-05 | PMCB | Pharmacyte Biotech, Inc. | Silverman Joshua | CEO, Pres | P - Purchase | $0.80 | +100,000 | 466,250 | +27% | +$80,476 | |||||
2025-12-16 | PPTIN | Presidio Property Trust, Inc. | Heilbron Jack Kendrick | CEO | P - Purchase | $3.29 | +10,000 | 15,061 | +198% | +$32,900 | ||||||
2025-12-26 | PPTIN | Presidio Property Trust, Inc. | Heilbron Jack Kendrick | CEO | P - Purchase | $2.82 | +10,000 | 25,061 | +66% | +$28,200 | ||||||
| M | 2025-12-19 | PROP | Prairie Operating Co. | Narrogal Nominees Pty Ltd Atf Gregory K O'Neill Family Trust | 10% | P - Purchase | $1.68 | +83,825 | 15,270,622 | +1% | +$140,826 | |||||
2025-12-29 | PROP | Prairie Operating Co. | Narrogal Nominees Pty Ltd Atf Gregory K O'Neill Family Trust | 10% | P - Purchase | $1.61 | +210,981 | 15,481,603 | +1% | +$339,806 | ||||||
2026-01-02 | RCKT | Rocket Pharmaceuticals, Inc. | Bjork Elisabeth | Dir | P - Purchase | $3.44 | +10,000 | 50,000 | +25% | +$34,400 | ||||||
2025-12-31 | RDGL | Vivos Inc | Korenko Michael K | CEO, Pres | P - Purchase | $0.06 | +200,000 | 10,935,090 | +2% | +$12,920 | ||||||
2026-01-06 | SFRX | Seafarer Exploration Corp | Kennedy Kyle | CEO | P - Purchase | $0.00 | +12,000,000 | 47,500,000 | +34% | +$15,600 | ||||||
2025-12-19 | SGRP | Spar Group, Inc. | Hennen Steven Michael | CFO | P - Purchase | $0.78 | +55,000 | 55,000 | New | +$42,900 | ||||||
2026-01-07 | SQNS | Sequans Communications | Asher Daniel | 10% | P - Purchase | $4.91 | +21,900 | 1,706,847 | +1% | +$107,514 | ||||||
| M | 2025-12-18 | SSGC | Safespace Global Corp | Hillis Dustin Michael | Pres, Chief Strat Officer | P - Purchase | $0.25 | +100,000 | 7,354,500 | +1% | +$25,095 | |||||
| M | 2025-12-19 | TCRX | Tscan Therapeutics, Inc. | Lynx1 Capital Management LP | 10% | P - Purchase | $0.90 | +161,801 | 15,956,564 | +1% | +$145,526 | |||||
2025-12-23 | TOFB | Tofutti Brands Inc | A-6684 Ltd. | 10% | P - Purchase | $0.72 | +55,000 | 689,500 | +9% | +$39,600 | ||||||
2025-12-23 | TXMD | Therapeuticsmd, Inc. | Thompson Tommy G | Dir | P - Purchase | $1.67 | +8,400 | 37,512 | +29% | +$14,031 | ||||||
| M | 2025-12-22 | UA | Under Armour, Inc. | Watsa V Prem Et Al | 10% | P - Purchase | $4.53 | +15,681,964 | 38,233,809 | +70% | +$70,963,523 | |||||
2025-12-23 | UPXI | Upexi, Inc. | Marshall Allan | CEO | P - Purchase | $1.80 | +50,000 | 4,046,261 | +1% | +$90,000 | ||||||
| M | 2025-12-19 | UUU | Universal Safety Products, Inc. | Ault Milton C III | Dir | P - Purchase | $4.98 | +3,588 | 167,392 | +2% | +$17,878 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |